Unlike point-of-care testing (POCT), which provides quick qualitative results, LC/MS/MS (liquid chromatography/dual mass spectrometry) is the industry’s most advanced quantitative assessment tool. With high-sensitivity and specificity LC/MS/MS enables you to assess your patients’ medication usage and adjust their regimen accordingly.
Importance of Trending
Assume you see a new patient who you feel is appropriate for opioid therapy, however, also tests positive for THC. You recommend that the patient discontinue THC use in order to consider initiating an opioid medication regimen.
With qualitative testing, this patient may test positive for THC, even after THC cessation. Quantitative testing will provide additional insight regarding the patients THC use by quantifying the level of THC present in the urine. Although quantitative testing is positive, the numeric trends may demonstrate that cessation has occurred.
Count on Insight Diagnostics to detect and quantify minute levels of drugs; across several classes simultaneously and even encompassing synthetic marijuana, bath salts, and new substances that are on the horizon. Our individualized, customizable reports are reliable, timely, fully transparent, and completely compliant with all industry guidelines and federal regulations.
Our individualized, customizable reports are reliable, timely, fully transparent, and completely compliant with all industry guidelines and federal regulations.
Insight Diagnostics covers the most comprehensive list of drugs to help determine adherence to a treatment program. Oral swabs are available for patients unable to provide urine samples:
- Alcohol/Alcohol Metabolites
- Antidepressants (SSRI)
- Illicit Drugs
- Kratom (Mitragynene)
- Muscle Relaxants
- Over-the-counter Drugs
- Substituted Cathinones
- Synthetic Marijuana
- Tricyclic Antidepressants
Complete list of individual drugs covered by LC/MS/MS
(CAN BE ORDERED INDIVIDUALLY OR AS A CLASS)